Pulike Biological Engineering, Inc. (SHA:603566)
China · Delayed Price · Currency is CNY 10.38
+0.14 (1.37%)
Jun 23, 2026, 3:00 PM CST
SHA:603566 Market Cap
SHA:603566 has a market cap or net worth of 3.5 billion as of June 22, 2026. Its market cap has decreased by -28.59% in one year.
Market Cap
3.50B
Enterprise Value
2.90B
Revenue
1.06B
Ranking
n/a
PE Ratio
20.43
Stock Price
10.38
Market Cap Chart
Since May 18, 2015, SHA:603566's market cap has decreased from 3.58B to 3.50B, a decrease of -2.09%. That is a compound annual growth rate of -0.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 3.50B | -17.62% |
| Dec 31, 2025 | 4.25B | -2.59% |
| Dec 31, 2024 | 4.36B | -44.34% |
| Dec 29, 2023 | 7.84B | -17.21% |
| Dec 30, 2022 | 9.47B | 36.16% |
| Dec 31, 2021 | 6.95B | 6.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ChemPartner PharmaTech | 3.79B |
| Assure Tech (Hangzhou) | 3.79B |
| Beijing Bohui Innovation Biotechnology Group | 3.64B |
| Kexing Biopharm | 3.59B |
| Shanghai Shen Lian Biomedical | 3.52B |
| Hefei Lifeon Pharmaceutical | 3.46B |
| Hinova Pharmaceuticals | 3.43B |
| Baolingbao Biology | 3.42B |